Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) Stock Price

OBIOStock

$5.36+113.33%52W

Market Cap$322.16M

P/E—

PEG Ratio—

Div yield—

Beta0.55

OBIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)24.75%

Price vs S&P 500 (4W)37.88%

VGM Score58.91

Book Value / Share (Quarterly)$0.87

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)111.68%

Cash Flow / Share (Quarterly)$-0.94

Price vs S&P 500 (YTD)19.13%

Gross Margin (TTM)99.46%

Net Profit Margin (TTM)-166.75%

EPS (TTM)$-1.13

10-Day Avg Trading Volume0.44M

EPS Excl Extra (TTM)$-1.13

Revenue Growth (5Y)42.49%

EPS (Annual)$-1.10

ROI (Annual)-67.87%

Gross Margin (Annual)99.43%

Net Profit Margin (5Y Avg)-1115.45%

Cash / Share (Quarterly)$1.61

Revenue Growth QoQ (YoY)-87.33%

ROA (Last FY)-45.88%

Revenue Growth TTM (YoY)1033.89%

EBITD / Share (TTM)$-1.02

ROE (5Y Avg)-227.70%

Operating Margin (TTM)-167.96%

Cash Flow / Share (Annual)$-0.87

P/B Ratio5.25x

P/B Ratio (Quarterly)4.88x

Net Income / Employee (Annual)$-612,800

EV / Revenue (TTM)7.74x

Net Interest Coverage (TTM)-57.95x

ROA (TTM)-60.10%

EPS Incl Extra (Annual)$-1.10

Current Ratio (Annual)6.45x

Quick Ratio (Quarterly)6.90x

3-Month Avg Trading Volume0.31M

52-Week Price Return113.33%

Revenue / Employee (TTM)$380,500

P/S Ratio (Annual)7.99x

Asset Turnover (Annual)0.29x

52-Week High$5.78

Operating Margin (5Y Avg)-1154.70%

EPS Excl Extra (Annual)$-1.10

CapEx CAGR (5Y)-1.96%

26-Week Price Return36.00%

Quick Ratio (Annual)6.37x

13-Week Price Return32.68%

Total Debt / Equity (Annual)0.23x

Current Ratio (Quarterly)7.03x

Enterprise Value$253.43M

Revenue / Share Growth (5Y)31.23%

Asset Turnover (TTM)0.36x

Revenue / Employee (Annual)$389,300

Inventory Turnover (Annual)0.79x

Pretax Margin (Annual)-157.40%

Cash / Share (Annual)$1.87

3-Month Return Std Dev63.03%

Gross Margin (5Y Avg)95.31%

Net Income / Employee (TTM)$-634,500

ROE (Last FY)-83.15%

Net Interest Coverage (Annual)-31.02x

EPS Basic Excl Extra (Annual)$-1.10

Receivables Turnover (TTM)378.31x

Total Debt / Equity (Quarterly)0.28x

EPS Incl Extra (TTM)$-1.13

Receivables Turnover (Annual)358.10x

ROI (TTM)-101.25%

P/S Ratio (TTM)8.17x

Pretax Margin (5Y Avg)-1115.45%

Revenue / Share (Annual)$0.70

Price vs S&P 500 (52W)95.02%

Year-to-Date Return31.08%

5-Day Price Return-3.89%

EPS Normalized (Annual)$-1.10

ROA (5Y Avg)-76.56%

Net Profit Margin (Annual)-157.40%

Month-to-Date Return36.68%

EBITD / Share (Annual)$-1.08

Operating Margin (Annual)-154.73%

LT Debt / Equity (Annual)0.23x

ROI (5Y Avg)-99.22%

LT Debt / Equity (Quarterly)0.28x

EPS Basic Excl Extra (TTM)$-1.13

P/B Ratio (Annual)3.70x

Inventory Turnover (TTM)0.86x

Pretax Margin (TTM)-166.75%

Book Value / Share (Annual)$1.11

Price vs S&P 500 (13W)29.89%

Beta0.55x

Revenue / Share (TTM)$0.52

ROE (TTM)-137.82%

52-Week Low$2.20

vGradeD

gGradeB

mGradeA

vgmGradeC

OBIO Earnings Surprise History

Q2 25-0.50est. -0.51

Q3 25-0.40est. -0.40

Q4 250.26est. -0.38

Q2 26-0.37est. -0.37

OBIO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.07

4.08

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares	D	B	A	$5.36
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Orchestra BioMed Holdings, Inc. Ordinary Shares

Orchestra BioMed Holdings Inc is a biomedical company that develops innovative medical device technologies through strategic partnerships with established device manufacturers. The company's flagship products include BackBeat Cardiac Neuromodulation Therapy for treating hypertension and Virtue Sirolimus AngioInflusionBalloon for treating atherosclerotic artery disease. Its partnership-enabled model reduces development risk by sharing the burden with commercialization partners while accelerating time to market for its product candidates.